Clinical Trial Update: Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating recombinant interferon alpha in combination with etoposide for relapsed osteosarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Etoposide (Etoposide)
• Recombinant Interferon Alpha (Interferon alfa)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Osteosarcoma | Phase 2 | Status: COMPLETED